By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – BioNanomatrix today said it has closed a $23.3 million Series B financing round.

Leading the round was Domain Associates. New investor Gund Investment and existing investors Battelle Ventures, Innovation Valley Partners, and KT Venture Group also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.